2014
DOI: 10.1161/circheartfailure.113.001023
|View full text |Cite
|
Sign up to set email alerts
|

Novel Protective Role of Endogenous Cardiac Myocyte P2X4 Receptors in Heart Failure

Abstract: Background-Heart failure (HF), despite continuing progress, remains a leading cause of mortality and morbidity. P2X4 receptors (P2X4R) have emerged as potentially important molecules in regulating cardiac function and as potential targets for HF therapy. Transgenic P2X4R overexpression can protect against HF, but this does not explain the role of native cardiac P2X4R. Our goal is to define the physiological role of endogenous cardiac myocyte P2X4R under basal conditions and during HF induced by myocardial infa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
29
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 28 publications
(31 citation statements)
references
References 30 publications
2
29
0
Order By: Relevance
“…Nifuroxazide is an anti-diarrheal agent that inhibits signal transducer and activator of transcription 3 (STAT3) ( Nelson et al, 2008 ), a transcription factor that plays well-described roles in cardiac hypertrophy and failure ( Haghikia et al, 2011 ). Although ivermectin shows anti-tumor activity ( Hashimoto et al, 2009 ; Liu et al, 2016 ; Nishio et al, 2016 ), enhances cardiomyocyte contractility ( Yang et al, 2014 ), and is neuroprotective ( Andries et al, 2007 ), few reports have addressed its effects on mitochondrial function in cardiomyocytes or cardiac hypertrophy. Therefore, we focused on ivermectin and its mechanism of action by assessing the effects of known ivermectin molecular targets on mitochondrial ATP under hypoxia.…”
Section: Resultsmentioning
confidence: 99%
“…Nifuroxazide is an anti-diarrheal agent that inhibits signal transducer and activator of transcription 3 (STAT3) ( Nelson et al, 2008 ), a transcription factor that plays well-described roles in cardiac hypertrophy and failure ( Haghikia et al, 2011 ). Although ivermectin shows anti-tumor activity ( Hashimoto et al, 2009 ; Liu et al, 2016 ; Nishio et al, 2016 ), enhances cardiomyocyte contractility ( Yang et al, 2014 ), and is neuroprotective ( Andries et al, 2007 ), few reports have addressed its effects on mitochondrial function in cardiomyocytes or cardiac hypertrophy. Therefore, we focused on ivermectin and its mechanism of action by assessing the effects of known ivermectin molecular targets on mitochondrial ATP under hypoxia.…”
Section: Resultsmentioning
confidence: 99%
“…In cardiac fibroblasts, P2X4 and P2X7 mRNAs have been detected in cultured human ventricular fibroblasts [46]. Furthermore, cardiac myocyte-specific overexpression of the P2X4 receptor in mice decreases fibrosis in a hypertensive heart failure mouse model [114,115], yet it is unknown whether this is due to direct cardiac myocyte protection or the interaction between cardiac myocytes and fibroblasts [116]. The function of P2X4 and P2X7 in mediating Ca 2+ entry in cardiac fibroblasts and their role in cardiac fibrosis needs further investigation.…”
Section: Ca 2+ Entry Mediated By P2x Receptorsmentioning
confidence: 99%
“…Our findings, when considered in conjunction with previous work on purinergic responses in mammalian cardiac myocytes, provide new insights into the complex multifactorial purinergic signalling system in the ventricular myocardium (Vassort, ). It is well established that ATP can exhibit positive inotropic effects in the heart, both in control conditions and in the setting of experimental cardiomyopathy (Vassort, ; Yang et al., ). Although extensive electrophysiological studies have been done on a variety of different isolated single myocyte preparations, the explanation for this consistent positive inotropic effect remains to be determined.…”
Section: Discussionmentioning
confidence: 99%